Login to Your Account

Medarex Shares Take Hit Amid Pfizer's Halted Melanoma Trial

By Catherine Hollingsworth

Thursday, April 3, 2008
Medarex shares plummeted Wednesday as partner Pfizer Inc. unexpectedly halted a Phase III trial of potential melanoma treatment tremelimumab. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription